Point72 Asset Management L.P. 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:46 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Point72 Asset Management L.P. | 225,463 0.300% |
-2,999,111 (-93.01%) |
Filing |
| 2021-05-13 4:34 pm Purchase |
2021-05-04 | 13G | Global Blood Therapeutics, Inc. GBT |
Point72 Asset Management L.P. | 3,224,574 5.200% |
2,797,541 (+655.11%) |
Filing |